These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3930567)

  • 1. In vitro susceptibility of Pseudomonas species to carbenicillin and trimethoprim-sulfamethoxazole.
    Hill SF; Haldane DJ; Ngui-Yen JH; Smith JA
    J Clin Microbiol; 1985 Sep; 22(3):465-6. PubMed ID: 3930567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of Pseudomonas aeruginosa to colistin combined with carbenicillin or sulfamethoxazole.
    Dalton AC; Plaut ME
    Am J Med Sci; 1971 Jun; 261(6):335-40. PubMed ID: 5004712
    [No Abstract]   [Full Text] [Related]  

  • 3. Susceptibility of Pseudomonas maltophilia to antimicrobial agents, singly and in combination.
    Felegie TP; Yu VL; Rumans LW; Yee RB
    Antimicrob Agents Chemother; 1979 Dec; 16(6):833-7. PubMed ID: 533264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of different Pseudomonas species and Aeromonas hydrophila to trimethoprim and sulfamethoxazole separately and in combination.
    Nord CE; Wadström T; Wretlind B
    Med Microbiol Immunol; 1974; 160(1):1-7. PubMed ID: 4214032
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of minimal amounts of thymidine on activity of trimethoprim-sulfamethoxazole against Staphylococcus epidermidis.
    Jones C; Stevens DL; Ojo O
    Antimicrob Agents Chemother; 1987 Feb; 31(2):144-7. PubMed ID: 3494425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the suitability of three common bacterial media for susceptibility testing of trimethoprim-sulfamethoxazole.
    Ferguson RW; Weissfeld AS
    J Clin Microbiol; 1984 Jan; 19(1):85-6. PubMed ID: 6418766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Pseudomonas aeruginosa by ascorbic acid-sulphamethoxazole-trimethoprim combination.
    Rawal BD; Charles BG
    Southeast Asian J Trop Med Public Health; 1972 Jun; 3(2):225-8. PubMed ID: 4628346
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibacterial action of trimethoprim-sulfamethoxazole.
    Gallien R
    J Infect Dis; 1973 Nov; 128():Suppl:486-97 p. PubMed ID: 4202206
    [No Abstract]   [Full Text] [Related]  

  • 9. Spurious sulfamethoxazole-trimethoprim resistance of Salmonella typhi.
    Escamilla J; Kilpatrick ME; Ugarte HF
    J Clin Microbiol; 1986 Jan; 23(1):205-6. PubMed ID: 3486190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-trimoxazole susceptibility tests improved with separate trimethoprim and sulfamethoxazole disks.
    Amyes SG
    J Clin Microbiol; 1981 Apr; 13(4):613-7. PubMed ID: 7014612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combinations of antimicrobial agents. III. The in vitro sensitivity of 12 strains of Pseudomonas aeruginosa and 12 strains of proteus species ot sulphamethoxazole + trimethoprim (co-trimoxazole), polymyxins and combinations of co-trimoxazole and polymyxins.
    Kuipers JS
    Arch Chir Neerl; 1976; 28(2):91-9. PubMed ID: 823875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility of Pseudomanas cepacia and Pseudomonas maltophilia to trimethoprim and trimethoprim-sulfamethoxazole.
    Moody MR; Young WM
    Antimicrob Agents Chemother; 1975 Jun; 7(6):836-9. PubMed ID: 1155926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Susceptibility of gram negative bacteria to TMP-SMX and ofloxacin].
    Unal S; Aydin M; Akin A
    Mikrobiyol Bul; 1988; 22(4):316-21. PubMed ID: 3266971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of Pseudomonas aeruginosa to sulphonamides and trimethoprim and the activity of the combination trimethoprim: sulphamethoxazole.
    Grey D; Hamilton-Miller JM
    J Med Microbiol; 1977 Aug; 10(3):273-9. PubMed ID: 408490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic interaction in vitro with use of three antibiotics simultaneously against Pseudomonas maltophilia.
    Yu VL; Felegie TP; Yee RB; Pasculle AW; Taylor FH
    J Infect Dis; 1980 Oct; 142(4):602-7. PubMed ID: 7441019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norfloxacin (MK-0366, AM-715): in vitro activity and cross-resistance with other organic acids including quality control limits for disk diffusion testing.
    Jones RN; Barry AL
    Diagn Microbiol Infect Dis; 1983 Jun; 1(2):165-72. PubMed ID: 6232084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the sensitivity of pseudomonas and proteus to the combination of trimethoprim and sulphamethoxazole.
    Ritzerfeld W; Hasch B
    Chemotherapy; 1972; 17(5):348-55. PubMed ID: 4205551
    [No Abstract]   [Full Text] [Related]  

  • 18. Synergistic effect of combinations of sulfamethoxazole, trimethoprim, and colistin against Pseudomonas maltophilia and Pseudomonas cepacia.
    Nord CE; Wadström T; Wretlind B
    Antimicrob Agents Chemother; 1974 Oct; 6(4):521-3. PubMed ID: 4143759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of recently isolated pathogenic bacteria to trimethoprim and sulfamethoxazole separately and combined.
    Bach MC; Finland M; Gold O; Wilcox C
    J Infect Dis; 1973 Nov; 128():Suppl:508-33 p. PubMed ID: 4148416
    [No Abstract]   [Full Text] [Related]  

  • 20. [Various methods to assay carbenicillin activity against Pseudomonas aeruginosa].
    Litovchenko PP; Dekhtiar NV; Keĭsevich LV; Lukach IG
    Antibiot Khimioter; 1991 Nov; 36(11):17-21. PubMed ID: 1793288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.